PreveCeutical Medical ( (TSE:PREV) ) has shared an announcement.
PreveCeutical Medical Inc. announced an extension from the Canadian Securities Exchange to close its non-brokered private placement, aiming to raise up to CDN$300,000 by April 24, 2025. This move is part of the company’s strategic efforts to secure necessary funding for its ongoing research and development programs, potentially strengthening its position in the health sciences industry.
More about PreveCeutical Medical
PreveCeutical Medical Inc. is a health sciences company focused on developing innovative preventive and curative therapies using organic and nature identical products. The company aims to lead in preventive health sciences with research and development programs targeting diabetes, obesity, pain management, and concussion treatment.
Average Trading Volume: 115,569
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $9.42M
See more data about PREV stock on TipRanks’ Stock Analysis page.